Brain Dev. 2017 Aug;39(7):629-632. doi: 10.1016/j.braindev.2017.02.007. Epub 2017 Mar 25.
Shimoda K1, Mimaki M2, Fujino S2, Takeuchi M2, Hino R3, Uozaki H4, Hayashi M5, Oka A2, Mizuguchi M6.
Author information
- 1
- Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Japan. Electronic address: konomi-@mbb.nifty.ne.jp.
- 2
- Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Japan.
- 3
- Department of Pathology, Graduate School of Medicine, The University of Tokyo, Japan.
- 4
- Department of Pathology, Graduate School of Medicine, The University of Tokyo, Japan; Department of Pathology, Graduate School of Medicine, The University of Teikyo, Japan.
- 5
- Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Japan.
- 6
- Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Japan; Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, Japan.
Abstract
Ataxia-telangiectasia is a chronic progressive disorder affecting the nervous and immune systems, caused by a genetic defect in the ATM protein. Clasmatodendrosis, a distinct form of astroglial death, has rarely been reported in ataxia-telangiectasia. Neuropathology of our patient disclosed diffuse edema of the cerebral and cerebellar white matter with prominent clasmatodendrosis, implicating ATM in the regulation of astroglial cell death.
KEYWORDS:
Ataxia-telangiectasia; Clasmatodendrosis; NF-kappa B; Tumor suppressor protein p53
- PMID:
- 28351596
- DOI:
- 10.1016/j.braindev.2017.02.007
- [Indexed for MEDLINE]